ST14 antibody (AA 566-855)
-
- Target See all ST14 Antibodies
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
-
Binding Specificity
- AA 566-855
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This ST14 antibody is un-conjugated
-
Application
- ELISA, Immunohistochemistry (IHC)
- Cross-Reactivity
- Human
- Purification
- Antigen Affinity purified
- Immunogen
- Recombinant Human Suppressor of tumorigenicity 14 protein (566-855AA)
- Isotype
- IgG
- Top Product
- Discover our top product ST14 Primary Antibody
-
-
- Application Notes
- Recommended dilution: IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
- Alternative Name
- ST14 (ST14 Products)
- Synonyms
- HAI antibody, MT-SP1 antibody, MTSP1 antibody, PRSS14 antibody, SNC19 antibody, TADG15 antibody, TMPRSS14 antibody, XMT-SP1 antibody, hai antibody, mt-sp1 antibody, mtsp1 antibody, prss14 antibody, snc19 antibody, st14 antibody, st14a antibody, tadg15 antibody, tmprss1 antibody, Epithin antibody, Prss14 antibody, Tmprss14 antibody, mCAP3 antibody, matriptase antibody, suppression of tumorigenicity 14 antibody, suppression of tumorigenicity 14 L homeolog antibody, suppression of tumorigenicity 14 (colon carcinoma) antibody, ST14 antibody, st14.L antibody, St14 antibody
- Background
-
Background: Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing.
Aliases: Epithin antibody, HAI antibody, Matriptase antibody, Membrane type serine protease 1 antibody, Membrane type serine protease antibody, Membrane-type serine protease 1 antibody, MT SP1 antibody, MT-SP1 antibody, MTSP 1 antibody, MTSP1 antibody, Prostamin antibody, PRSS 14 antibody, PRSS14 antibody, Serine protease 14 antibody, Serine protease TADG 15 antibody, Serine protease TADG-15 antibody, Serine protease TADG15 antibody, SNC 19 antibody, SNC19 antibody, ST 14 antibody, ST14 antibody, ST14_HUMAN antibody, Suppression of tumorigenicity 14 (colon carcinoma matriptase epithin) antibody, Suppression of tumorigenicity 14 (colon carcinoma) antibody, Suppression of tumorigenicity 14 antibody, Suppressor of tumorigenicity 14 protein antibody, Suppressor of tumorigenicity protein 14 antibody, TADG 15 antibody, TADG15 antibody, TMPRSS14 antibody, Tumor associated differentially expressed gene 15 protein antibody, Tumor-associated differentially-expressed gene 15 protein antibody
- UniProt
- Q9Y5Y6
-